Instrument Inactif

Autres langues Pfizer Inc NYSE

Actions

Produits pharmaceutiques

Cours en clôture NYSE
- ^USD	-

16:32	Le secteur pharmaceutique mise massivement sur l'IA dans l'espoir de réduire les coûts et les délais	RE
19/08	Moderna et Merck : une percée qui pourrait ouvrir la voie à une vague de vaccins contre le cancer	RE

Autres langues

16:32	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
07:56	MORNING BRIEFING - USA/Asien
07:31	MORNING BRIEFING - Deutschland/Europa
19/08	Moderna, Merck breakthrough could usher in wave of cancer vaccines
19/08	MÄRKTE USA/Entspannung am Anleihemarkt hebt Stimmung - Kursexplosion bei Moderna
18/08	GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
18/08	Pfizer Pick of the Week at Smart Insider Following CEO's First Share Purchase
14/08	Health Care Down on Growth Doubts - Health Care Roundup
14/08	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate
14/08	Aktien Europa Schluss: Zurückhaltung vor dem Wochenende
14/08	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate
14/08	Valneva Shares Climb After Lyme Disease Vaccine Receives EMA Application Acceptance
14/08	Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
14/08	Valneva Shares Gain as Lyme Vaccine Candidate Gets EMA Review
14/08	Pfizer, Valneva Lyme Disease Vaccine Candidate Set for EMA Review
14/08	EU Validates Pfizer, Valneva's Application for Lyme Vaccine Candidate
12/08	Pfizer Insider Bought Shares Worth $1,000,920, According to a Recent SEC Filing
11/08	Global drugmakers invest billions to boost US presence
11/08	Trump streicht Empfehlungen für Kinderimpfungen zusammen
10/08	S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says
10/08	Bristol Myers to build $2.3 billion manufacturing site in Houston
07/08	Murray International net assets rise but performance lags benchmark
05/08	Merck's Keytruda Gets Canadian Approval to Treat Muscle-Invasive Bladder Cancer
05/08	MORNING BRIEFING - USA/Asien
05/08	MORNING BRIEFING - Deutschland/Europa -2-